| Product Code: ETC071588 | Publication Date: Jun 2021 | Updated Date: Jun 2026 | Product Type: Report | |
| Publisher: 6Wresearch | Author: Shubham Deep | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 |
The Nigeria Infectious Disease Rapid Diagnostic Testing Market was estimated at USD 140 Million in 2025 and is projected to reach USD 153 Million by 2032, growing at a CAGR of 1.3% from 2026 to 2032. This growth trajectory is predominantly driven by the escalating rates of infectious diseases, including malaria and HIV/AIDS, which necessitate timely and accurate diagnostic solutions. The Nigerian government's commitment to enhancing healthcare infrastructure and increasing awareness around the importance of early detection further fuels this demand, ensuring that healthcare providers are equipped with advanced testing capabilities.
The Nigeria Infectious Disease Rapid Diagnostic Testing market experienced a challenging decline of 3.9% in 2021, largely due to disruptions from the pandemic that affected supply chains and healthcare access. However, the market rebounded swiftly in 2022, returning to growth at 5.3%, and reaching 5.8% in 2023, fueled by increased investments in healthcare infrastructure and heightened consumer demand for rapid testing solutions. This upward trend is projected to continue, albeit at a slower pace, with growth rates stabilizing at around 1.0% by 2027. Factors like advancements in testing technology and supportive governmental policies aimed at improving disease management will play crucial roles in sustaining this momentum through the coming years.
This graph highlights how the Nigeria Infectious Disease Rapid Diagnostic Testing Market has steadily grown over the past five years, supported by major growth factors.

The table below presents the year‑wise growth rates along with the key drivers influencing the market
| Year | Growth Rate | Major Drivers |
| 2021 | -3.9% | Increasing smart city development projects |
| 2022 | 5.3% | Increasing industrial infrastructure investments |
| 2023 | 5.8% | Growing renewable energy integration projects |
| 2024 | 0.5% | Increasing industrial automation investments |
| 2025 | 0.3% | Increasing industrial infrastructure investments |
| 2026 | 1.5% | Increasing industrial automation investments |
| 2027 | 1.0% | Expansion of transportation and logistics networks |
| 2028 | 2.1% | Government infrastructure modernization initiatives |
| 2029 | 1.9% | Expansion of manufacturing activities |
| 2030 | 2.1% | Expansion of transportation and logistics networks |
| 2031 | 1.1% | Rising electricity demand across industries |
| 2032 | 1.3% | Increasing adoption of advanced technologies |
Note - Market size estimations and growth projections presented in this report are based on 6Wresearch’s advanced forecasting approach, validated with industry datasets as of June 2026.
The market for rapid diagnostic testing in Nigeria is underscored by a pressing need for accessible and efficient testing solutions, especially in remote and underserved regions. With a growing focus on point-of-care testing, healthcare facilities are increasingly adopting rapid tests that yield immediate results, significantly improving patient management and treatment timelines.
Moreover, the proactive measures taken by healthcare authorities to distribute rapid diagnostic kits across the nation are pivotal. This strategy not only elevates testing availability but also aligns with international public health goals aimed at curbing the spread of infectious diseases, thus positioning Nigeria as a vital player in the regional health landscape.
The Nigeria Infectious Disease Rapid Diagnostic Testing Market faces several restraints that limit its full potential. Among these are infrastructural inadequacies, particularly in rural areas, which impede access to advanced diagnostic technologies. Furthermore, a general lack of awareness regarding the critical importance of early disease detection poses a significant hurdle. Affordability remains a pressing concern for many Nigerians, potentially restricting their access to rapid testing solutions. Navigating regulatory challenges and ensuring the quality and accuracy of testing kits also play a role in stalling market advancement. It will be essential to foster collaborations between government bodies, healthcare providers, and diagnostic firms to address these challenges effectively.
Several prominent trends are currently shaping the Nigeria Infectious Disease Rapid Diagnostic Testing Market. A marked shift toward point-of-care testing is evident as healthcare providers seek rapid solutions for conditions such as malaria, HIV, and tuberculosis. Technological advancements are also paving the way for the development of multiplex testing systems, which can concurrently identify various pathogens. Additionally, the integration of digital tools for result management and interpretation is on the rise, further enhancing the efficiency of diagnostic processes. The expansion of distribution networks to reach marginalized populations is a trend that underscores the commitment to equitable healthcare.
The market presents abundant investment opportunities, especially in the realms of technology development and distribution. The increasing prevalence of infectious diseases serves as a catalyst for demand, particularly for tailored rapid diagnostic tests designed to meet the specific needs of the Nigerian populace. Collaborations with local healthcare providers and NGOs are valuable strategies to enhance market penetration and ensure these solutions reach the broader community. Furthermore, the emphasis on early detection and treatment creates a fertile ground for innovative diagnostic solutions that can transform public health outcomes in the country.
The Nigerian government has launched multiple initiatives to bolster the Infectious Disease Rapid Diagnostic Testing Market. The establishment of the Nigeria Centre for Disease Control (NCDC) plays a pivotal role in coordinating infectious disease surveillance and response efforts. Policies prioritizing the procurement and distribution of rapid testing kits are key components of the government’s strategy to enhance healthcare delivery. Regulatory bodies oversee the quality and accuracy of diagnostic tests, ensuring that only reliable products are available to healthcare providers. These initiatives reflect a concerted effort to improve early detection rates and public health outcomes.
Looking ahead, the Nigeria Infectious Disease Rapid Diagnostic Testing Market is set to witness substantial growth driven by the rising awareness of early disease detection and treatment. The continued focus on improving healthcare infrastructure and expanding access to rapid tests in remote areas will be critical. Moreover, technological advancements are likely to lead to the creation of more efficient, cost-effective diagnostic solutions. As these trends take shape, the market will face challenges, particularly related to regulatory processes and access in hard-to-reach areas. Nevertheless, the overall outlook remains optimistic for the next several years.
In recent months, there have been notable advancements in the Nigeria Infectious Disease Rapid Diagnostic Testing Market, focusing on enhancing the distribution of rapid testing kits. New partnerships have been formed between diagnostic companies and public health entities aimed at improving awareness and accessibility. Innovative testing solutions are also being developed, catering specifically to the regional context, with an emphasis on affordability and ease of use. These developments are indicative of a broader trend towards integrating technology and healthcare delivery in Nigeria.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Nigeria Infectious Disease Rapid Diagnostic Testing Market Overview |
3.1 Nigeria Country Macro Economic Indicators |
3.2 Nigeria Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, 2022 & 2032F |
3.3 Nigeria Infectious Disease Rapid Diagnostic Testing Market - Industry Life Cycle |
3.4 Nigeria Infectious Disease Rapid Diagnostic Testing Market - Porter's Five Forces |
3.5 Nigeria Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume Share, By Form, 2022 & 2032F |
3.6 Nigeria Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume Share, By Technology, 2022 & 2032F |
3.7 Nigeria Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume Share, By End-users, 2022 & 2032F |
4 Nigeria Infectious Disease Rapid Diagnostic Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infectious diseases in Nigeria |
4.2.2 Government initiatives to improve healthcare infrastructure and access |
4.2.3 Growing awareness about the importance of early disease detection |
4.3 Market Restraints |
4.3.1 Lack of skilled healthcare professionals for conducting rapid diagnostic tests |
4.3.2 Limited access to advanced diagnostic technologies in remote areas |
4.3.3 High cost associated with rapid diagnostic testing kits |
5 Nigeria Infectious Disease Rapid Diagnostic Testing Market Trends |
6 Nigeria Infectious Disease Rapid Diagnostic Testing Market, By Types |
6.1 Nigeria Infectious Disease Rapid Diagnostic Testing Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Nigeria Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By Product, 2022-2032F |
6.1.3 Nigeria Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By Assays, Kits and Reagents, 2022-2032F |
6.1.4 Nigeria Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By Instruments, 2022-2032F |
6.1.5 Nigeria Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By Services and Software, 2022-2032F |
6.2 Nigeria Infectious Disease Rapid Diagnostic Testing Market, By Technology |
6.2.1 Overview and Analysis |
6.2.2 Nigeria Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By Immunodiagnostics, 2022-2032F |
6.2.3 Nigeria Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By Clinical Microbiology, 2022-2032F |
6.2.4 Nigeria Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By PCR, 2022-2032F |
6.2.5 Nigeria Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By INAAT, 2022-2032F |
6.2.6 Nigeria Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By DNA Sequencing and NGS, 2022-2032F |
6.2.7 Nigeria Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By Other Technologies, 2022-2032F |
6.3 Nigeria Infectious Disease Rapid Diagnostic Testing Market, By End-users |
6.3.1 Overview and Analysis |
6.3.2 Nigeria Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By Physician Offices, 2022-2032F |
6.3.3 Nigeria Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By Reference Laboratories, 2022-2032F |
6.3.4 Nigeria Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By Hospitals, 2022-2032F |
6.3.5 Nigeria Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By Academic and Research Institutes, 2022-2032F |
6.3.6 Nigeria Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By Others, 2022-2032F |
7 Nigeria Infectious Disease Rapid Diagnostic Testing Market Import-Export Trade Statistics |
7.1 Nigeria Infectious Disease Rapid Diagnostic Testing Market Export to Major Countries |
7.2 Nigeria Infectious Disease Rapid Diagnostic Testing Market Imports from Major Countries |
8 Nigeria Infectious Disease Rapid Diagnostic Testing Market Key Performance Indicators |
8.1 Average turnaround time for test results |
8.2 Percentage increase in the adoption of rapid diagnostic testing compared to traditional methods |
8.3 Number of partnerships with local healthcare facilities for rapid diagnostic testing services |
9 Nigeria Infectious Disease Rapid Diagnostic Testing Market - Opportunity Assessment |
9.1 Nigeria Infectious Disease Rapid Diagnostic Testing Market Opportunity Assessment, By Product, 2022 & 2032F |
9.2 Nigeria Infectious Disease Rapid Diagnostic Testing Market Opportunity Assessment, By Technology, 2022 & 2032F |
9.3 Nigeria Infectious Disease Rapid Diagnostic Testing Market Opportunity Assessment, By End-users, 2022 & 2032F |
10 Nigeria Infectious Disease Rapid Diagnostic Testing Market - Competitive Landscape |
10.1 Nigeria Infectious Disease Rapid Diagnostic Testing Market Revenue Share, By Companies, 2025 |
10.2 Nigeria Infectious Disease Rapid Diagnostic Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here